secwatch.observer — SEC 8-K summary
======================================

Issuer:     Myovant Sciences Ltd. (—)
CIK:        0001679082
Form:       8-K
Filed at:   2023-03-10T23:59:59+00:00
Accession:  0001140361-23-011046
Event type: m_and_a
Sentiment:  neutral
Materiality: 1.00
Item codes: 2.01, 3.01, 3.03, 5.01, 5.02, 5.03, 8.01, 9.01
LLM model:  deepseek-v4-flash:cloud@v2

Sumitovant completes $1.7B acquisition of Myovant; shareholders receive $27.00/share
--------------------------------------------------------------------------------

- Myovant shareholders received $27.00 per share in cash; total transaction value ~$1.7B.
- Myovant shares delisted from NYSE as of March 10, 2023; deregistration to follow.
- All Myovant directors replaced; new board consists of Adele Gulfo, Myrtle Potter, Shigeyuki Nishinaka.
- Equity awards cashed out; options and RSUs converted to cash at $27.00/share subject to exercise price.

Source:
  EDGAR index:    https://www.sec.gov/Archives/edgar/data/1679082/000114036123011046/0001140361-23-011046-index.htm
  Primary doc:    https://www.sec.gov/Archives/edgar/data/1679082/000114036123011046/ny20008100x2_8k.htm
  HTML page:      https://secwatch.observer/filing/0001140361-23-011046

License: Source filings: public domain (SEC EDGAR). Summaries (headline + bullets): CC-BY-4.0; attribute https://secwatch.observer